InvestorsHub Logo
Followers 2
Posts 251
Boards Moderated 0
Alias Born 05/29/2019

Re: None

Friday, 10/30/2020 3:36:18 PM

Friday, October 30, 2020 3:36:18 PM

Post# of 232887
This is great news for LL- one more competitor moved off the field. Not so good for the S/C pt.s that signed up for the clinical trial- Godspeed to them.. But maybe, just maybe, some MD's can add them to the LL trial?

"The partial study hold indicates that the promising class of monoclonal antibodies might not work in hospitalized patients with the most severe cases of Covid-19. On Monday, a study of Eli Lilly’s monoclonal antibody in hospitalized patients was terminated after it was determined the drug was unlikely to provide a benefit."

https://www.wsj.com/articles/trial-of-covid-19-antibody-drug-regeneron-is-halted-in-sickest-hospital-patients-11604071118?mod=hp_lead_pos6
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News